IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Chen, Miao Fen ^a,b   Lin, Paul Yang ^a,b   Wu, Ching Fang ^a,b   Chen, Wen Cheng ^a,b   Wu, Chun Te ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; GELATINASE B; INTERLEUKIN 6; MESSENGER RNA; STAT3 PROTEIN; UVOMORULIN; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL PREDICTION; SURVIVAL RATE; TUMOR INVASION; TUMOR PROMOTION; TUMOR VASCULARIZATION; ANIMAL; BLADDER; DIAGNOSTIC USE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; URINARY BLADDER NEOPLASMS; VASCULARIZATION;

ANIMALIA;

ANIMALS; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RNA, MESSENGER; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84876990565     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061901     Document Type: Article

References (37)

1. Dinney CP, McConkey DJ, Millikan RE, Wu X, Bar-Eli M, et al. (2004) Focus on bladder cancer. Cancer Cell 6: 111-116.
2. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, et al. (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19: 666-675.
3. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-867.
4. Balkwill F, Mantovani A, (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
5. Gonda TA, Tu S, Wang TC, (2009) Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle 8: 2005-2013.
6. Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y, (2004) Cytokines in cancer immunity and immunotherapy. Immunol Rev 202: 275-293.
7. Abdel-Latif MM, Duggan S, Reynolds JV, Kelleher D, (2009) Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol 9: 396-404.
8. Zhu Z, Shen Z, Xu C, (2012) Mediators Inflamm. 2012: 528690.
9. Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, et al. (2009) Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell. 15: 283-93.
10. Kishimoto T, (2005) Interleukin-6: from basic science to medicine--40 years in immunology. Annu Rev Immunol 23: 1-21.
11. Schafer ZT, Brugge JS, (2007) IL-6 involvement in epithelial cancers. J Clin Invest 117: 3660-3663.
12. Chen CC, Chen WC, Lu CH, Wang WH, Lin PY, et al. (2010) Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor. Int J Radiat Oncol Biol Phys 76: 1214-1224.
13. Andrews B, Shariat SF, Kim JH, Wheeler TM, Slawin KM, et al. (2002) Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. J Urol 167: 1475-1481.
14. George DJ, Halabi S, Shepard TF, Sanford B, Vogelzang NJ, et al. (2005) The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480. Clin Cancer Res 11: 1815-1820.
15. Scambia G, Testa U, Benedetti Panici P, Foti E, Martucci R, et al. (1995) Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer 71: 354-356.
16. Liang CC, Park AY, Guan JL, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2(2): 329-33.
17. McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, et al. (2009) Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 28: 335-344.
18. Rieger-Christ KM, Ng L, Hanley RS, Durrani O, Ma H, et al. (2005) Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential. Br J Cancer 92: 2153-9.
19. Bromberg J, (2002) Stat proteins and oncogenesis. J Clin Invest 109: 1139-1142.
20. Sharma S, Sharma MC, Sarkar C, (2005) Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 46: 481-489.
21. Wu CT, Wu CF, Lu CH, Lin CC, Chen WC, et al. (2011) Expression and function role of DNA methyltransferase 1 in human bladder cancer. Cancer 117: 5221-5233.
22. Lin J, Guan Z, Wang C, Feng L, Zheng Y, et al. (2010) Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res 16: 77-87.
23. Levy DE, Darnell JE Jr, (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651-662.
24. Ho PL, Lay EJ, Jian W, Parra D, Chan KS, (2012) Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer. Cancer Res 72: 3135-42.
25. Reis ST, Leite KR, Piovesan LF, Pontes-Junior J, Viana NI, et al. (2012) Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer. BMC Urol. 12: 18.
26. Nakanishi R, Oka N, Nakatsuji H, Koizumi T, Sakaki M, et al. (2009) Effect of vascular endothelial growth factor and its receptor inhibitor on proliferation and invasion in bladder cancer. Urol Int. 83: 98-106.
27. Seguchi T, Yokokawa K, Sugao H, Nakano E, Sonoda T, et al. (1992) Interleukin-6 activity in urine and serum in patients with bladder carcinoma. J Urol 148: 791-794.
28. Kozin SV, Duda DG, Munn LL, Jain RK, (2012) Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors? J Natl Cancer Inst. 104(12): 899-905.
29. Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, et al. (2003) Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene. 22: 1517-27.
30. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, et al. (2009) Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci. 1171: 59-76.
31. Feinberg AP, Tycko B, (2004) The history of cancer epigenetics. Nat Rev Cancer 4: 143-153.
32. Wehbe H, Henson R, Meng F, Mize-Berge J, Patel T, (2006) Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res 66: 10517-10524.
33. Chen CC, Chen WC, Wang WH, Lu CH, Lin PY, et al. (2011) Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistance. Head Neck 33: 1132-1143.
34. Hodge DR, Cho E, Copeland TD, Guszczynski T, Yang E, et al. (2007) IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase. Cancer Genomics Proteomics 4: 387-398.
35. Lee SJ, Park SS, Cho YH, Park K, Kim EJ, et al. (2008) Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: the role of MAP kinase signaling pathways. Oncol Rep. 19: 1007-13.
36. Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, et al. (2003) Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin Cancer Res. 9: 3167-75.
37. Reis ST, Leite KR, Piovesan LF, Pontes-Junior J, Viana NI, et al. (2012) Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer. BMC Urol. 12: 18.